Mindset Pharma Expands Pipeline: Identifies Additional Next Generation 5-MeO-DMT-Inspired Lead Candidates Post published:September 29, 2021 Post category:Press Release
Red Light Holland: Initial Results From Red Light Oregon Market Research in Oregon Show 86% of Adults Interested in Psilocybin Services are Interested in Microdosing Post published:September 29, 2021 Post category:Press Release
MindMed Appoints University of North Carolina Psychiatrist and Pharmacologist Dr. Bryan Roth to Scientific Advisory Board Post published:September 29, 2021 Post category:Press Release
Psyence Group and Pure Extracts Finalize āPure Psyence,ā A Joint Venture for the Development of Psychedelic Medicinal Mushroom Extracts Post published:September 28, 2021 Post category:Press Release
PharmaTher Announces Closing of CAD$10 Million Private Placement with Institutional Investors Post published:September 28, 2021 Post category:Press Release
Psychedelic Research Bulletin: July & August 2021 Post published:September 28, 2021 Post category:Psychedelics Research Review
BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders Post published:September 27, 2021 Post category:Press Release
Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders Post published:September 27, 2021 Post category:Press Release
Toronto University Health Network Launches Psychedelic Psychotherapy Research Centre Post published:September 27, 2021 Post category:News
MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted Psychotherapy Post published:September 27, 2021 Post category:Press Release